Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

CARY PHARMACEUTICALS — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Termination (No Activity)

CARY PHARMACEUTICALS

via THE CONAFAY GROUP, LLC

1st Quarter (Jan 1 - Mar 31) · 2013Posted Apr 11, 2013Filing document ↗LDA record ↗

Income$30Kfee reported

Client

Name: CARY PHARMACEUTICALS
Description: a pharmaceutical development company-smoking cessationm catheter technology
Location: Virginia · United States of America

Registrant

Firm: THE CONAFAY GROUP, LLC
Description: Life Sciences Consulting Firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.